Skip to content

Clinical trials

Enrolling by invitation Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Enrolling by invitation Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20131
20201
20212
20235
20248
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zealand University Hospital2
Avistone Biotechnology Co., Ltd.1
Azienda Ospedaliero, Universitaria Pisana1
Ellen Margrethe Hauge1
First Affiliated Hospital of Kunming Medical University1
Fred Hutchinson Cancer Center1
Gene Solutions1
Harvard Medical School (HMS and HSDM)1
Icahn School of Medicine at Mount Sinai1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms23
Carcinoma, Non-Small-Cell Lung5
Pulmonary Disease, Chronic Obstructive5
Disease3
Anxiety Disorders2
Arthritis, Rheumatoid2
Brain Neoplasms2
Breast Neoplasms2
Cardiovascular Diseases2
Colonic Neoplasms2

Trials

Showing 76 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.